All Type of News
Emergency on pharmaceutical distribution companies to secure flu medicines
Since the flu spread across the nation, everyone got busy to secure the enough amount of supply for flu medicines.
As the flu rapidly spread among some schools, prescriptions on flu medicines have significantly incre...
Pharma industry’s concerns on rebates with CSO system
As it was known the police exposed illegal rebates and made a search and seizure on a distribution company, which has a directly business with a medium hospital in Gimhae, and CSOs(Contract Sales Organizations) on the...
Minister Jin-Yup Jung, “I will pass the issue over drug vending machine to National Assembly”
The Ministry of Health and Welfare(MOHW) passed over the implementation of video drug vending machines to the National Assembly.
As necessity of the implementation was suggested at the MOHW’s status report meeting on...
Health and Welfare Committee, “Having public pharmacists is understandable, must be socially agreed”
There was an opinion of the National Assembly Expert Committee that they need a social agreement on the adoption of the ‘public pharmacist’ system for agricultural and fishing communities although necessity of the sys...
Rapid increases in drug exportation followed by Korean pharmas’ strengthened capability
With acceleration in pioneering pharmerging and emerging markets and entering advanced biosimilar markets, this year’s amount of drug exports were anticipated to record USD 3.39 billion increased by 15.2% compared to ...
MFDS takes action to suspend Hanmi Pharm’s clinical trial for 3 months
The Ministry of Food and Drug Safety(MFDS) decided to take an administrative action to suspend a Hanmi Pharm’s clinical trial.
Minister Mun-gi Sohn of Food and Drug Safety participated the National Assembly Health an...
Celltrion’s Remsima challenges to Truxima’s KRW 8 trillion marketOn the 19th(local time), Celltrion announced it received ‘recommendation of approval’ for every indication of the world’s first hematological malignancy anticancer biosimilar Tr...
|
SK Chemicals’ hemophilia therapy ‘AFSTYLA’ approved in CanadaSK Chemicals(CEO Man-Hoon Park) announced on the 18th that its hemophilia treatment ‘AFSTYLA’ acquired commercialization approval from the Canadian health authorities Health Can...
|
Pharmas, “Hope impacts of the prosecution’s rebate investigation will be minimum…”
‘Hope the impact will be minimum…’
Since it was known the prosecution is about to announce the final investigation result on a hospital ‘J’ located in Jeonju, pharmaceutical companies have paid attention to the resul...
Multinational pharmas turned in status of advertising expenses to MOHW
While the general administrative investigation is expected over multinational pharmaceutical companies after the Novartis’ rebate incident, it was confirmed its related data is turned in to the Ministry of Health and ...
